Lv6
2365 积分 2021-10-12 加入
Structural basis of Nav1.7 inhibition by an isoform-selective small-molecule antagonist
1个月前
已完结
Novel analogues of ketamine and phencyclidine as NMDA receptor antagonists
4个月前
已完结
The N-terminal domain of the GluN3A subunit determines the efficacy of glycine-activated NMDA receptors
4个月前
已完结
Excitatory GluN1/GluN3A glycine receptors (eGlyRs) in brain signaling
4个月前
已完结
Competitive Gly/NMDA Receptor Antagonists
4个月前
已完结
Developing FGFR4 Inhibitors As Potential Anti-Cancer Agents Via In Silico Design, Supported by In Vitro and Cell-Based Testing
5个月前
已完结
AML-147 C-MYC Targeting by Degradation: Novel Dual c-Myc/GSPT1 Degrader GT19715 Exerts Profound Cell Kill In Vitro and In Vivo in Acute Myeloid Leukemia and Lymphomas
5个月前
已完结
First targeted protein degrader hits the clinic
5个月前
已完结
AML-147 C-MYC Targeting by Degradation: Novel Dual c-Myc/GSPT1 Degrader GT19715 Exerts Profound Cell Kill In Vitro and In Vivo in Acute Myeloid Leukemia and Lymphomas
9个月前
已完结
Discovery of A New Class of Valosine Containing Protein (VCP/P97) Inhibitors for the Treatment of Colorectal Cancer
1年前
已完结
皖公网安备34019202002308
